418747006: Hepatitis B surface antigen immunoglobulin (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Plasma protein (substance)\Immunoglobulin\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Plasma protein (substance)\Immunoglobulin\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)

\Biological substance (substance)\Protein and/or protein derivative\Protein\Plasma protein (substance)\Immunoglobulin\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)
\Biological substance (substance)\Blood material\Blood component\Plasma protein (substance)\Immunoglobulin\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)
\Biological substance (substance)\Polypeptide\Protein\Plasma protein (substance)\Immunoglobulin\Human immunoglobulin (substance)\Hepatitis B surface antigen immunoglobulin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3782556017 Hepatitis B surface antigen immunoglobulin (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

3782557014 Hepatitis B surface antigen immunoglobulin en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

3266711000005111 hepatitis b-overfladeantigen immunglobulin da Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hepatitis B surface antigen immunoglobulin (substance)	Is a	Immunoglobulin	false	Inferred relationship	Some
Hepatitis B surface antigen immunoglobulin (substance)	Is a	Human immunoglobulin (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hepatitis B immunoglobulin adverse reaction	Causative agent	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
allergi over for hepatitis B-immunglobulin	Causative agent	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 1000 IE pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 200 IE pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 500 IE pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
Hepatitis B surface antigen immunoglobulin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Anti-hbs immunoglobulin injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 1 enhed/hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 217 enheder injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 312 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
hepatitis B-immunglobulin 312 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some
allergi over for hepatitis B-immunglobulin	Causative agent	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing only Hepatitis B surface antigen immunoglobulin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Allergy to Hepatitis b surface antigen immunoglobulin	Causative agent	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
hepatitis B-immunglobulin 200 IE pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
hepatitis B-immunglobulin 500 IE pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 50 unit/mL solution for infusion and/or injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 50 unit/mL solution for infusion and/or injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hepatitis B surface antigen immunoglobulin (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3782556017	Hepatitis B surface antigen immunoglobulin (substance)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3782557014	Hepatitis B surface antigen immunoglobulin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3266711000005111	hepatitis b-overfladeantigen immunglobulin	da	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Danish module (core metadata concept)